Walgreens Boots Alliance (WBA)
(Delayed Data from NSDQ)
$8.77 USD
+0.03 (0.34%)
Updated Sep 6, 2024 04:00 PM ET
After-Market: $8.75 -0.02 (-0.23%) 5:02 PM ET
5-Strong Sell of 5 5
D Value D Growth A Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$8.77 USD
+0.03 (0.34%)
Updated Sep 6, 2024 04:00 PM ET
After-Market: $8.75 -0.02 (-0.23%) 5:02 PM ET
5-Strong Sell of 5 5
D Value D Growth A Momentum D VGM
Zacks News
The Zacks Analyst Blog Highlights: Phillip Morris, Bristol-Myers, Walgreens, Sirius and Total System
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Phillip Morris, Bristol-Myers, Walgreens, Sirius and Total System
Top Research Reports for Phillip Morris, Bristol-Myers & Walgreens Boots
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Phillip Morris (PM), Bristol-Myers (BMY) and Walgreens Boots (WBA).
Can Retail Pharmacy USA Lift Walgreens' (WBA) Q2 Earnings?
by Zacks Equity Research
Widening pharmacy network, healthy prescription volumes along with contributions from Rite Aid are expected to contribute to Walgreens Boots' (WBA) top line in the fiscal second quarter.
Buy Walgreens (WBA) Stock Ahead of Q2 Earnings, Before CBD Push?
by Benjamin Rains
Shares of Walgreens Boots Alliance, Inc. (WBA) have fallen roughly 9% this year, which stands in contrast to the market's nearly 13% climb and its industry's 4.5% average gains. But is it time to buy WBA stock ahead of earnings?
Walgreens Boots Alliance (WBA) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Walgreens Boots Alliance (WBA) closed at $61.92, marking a +0.37% move from the previous day.
Better Buy Amid Tech Diversification: Apple (AAPL) vs. Amazon (AMZN) Stock
by Benjamin Rains
Apple (AAPL) and Amazon (AMZN) are two of the largest companies on the planet. The tech powers have reshaped industries and changed the way millions of people function on a daily basis. But today, Apple and Amazon face possible transition periods as they try to expand their offerings to drive growth. So which stock, AAPL or AMZN, is a better buy?
Earnings Preview: Walgreens Boots Alliance (WBA) Q2 Earnings Expected to Decline
by Zacks Equity Research
Walgreens (WBA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Lululemon (LULU) Stock Looks Like a Buy Heading into Q4 Earnings
by Benjamin Rains
Lululemon (LULU) shares popped over 3% Thursday heading into the release of its fourth quarter financial results, as part of its larger 2019 climb. The yoga apparel and athleisure giant's bottom-line looks set to surge as it expands its menswear business, its global reach, and more.
Walgreens Boots Alliance (WBA) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed at $62.79 in the latest trading session, marking a -1.54% move from the prior day.
Amazon's HSA & FSA Payment Option to Boost Pharma Initiatives
by Zacks Equity Research
Amazon (AMZN) rolls out payment options via HSA and FSA for medical purchases made on its online platform which is likely to strengthen its healthcare market presence.
What to Expect from FedEx's (FDX) Q3 Earnings
by Benjamin Rains
Let's see what to expect from FedEx's Q3 fiscal 2019 financial results, which are due out Tuesday, with larger global market conditions possibly trending in the wrong direction for the shipping and logistics powerhouse.
Buy Amazon (AMZN) Stock on Earnings Growth & E-commerce Dominance?
by Benjamin Rains
Amazon (AMZN) shares have climbed roughly 13% to start the year, which tops the market's comeback, but falls way behind fellow FAANG giants Facebook (FB) and Netflix (NFLX). Therefore, Amazon stock still rests over 17% below its 52-week high.
CVS Health Stock Jumps on Bullish Coverage: Time to Buy?
by Benjamin Rains
Shares of CVS Health (CVS) surged over 4% through mid-afternoon trading Wednesday on the back of a bullish call from Bernstein analysts. The drugstore chain is also coming off a stronger-than-expected fourth quarter. So, is now the time to buy CVS stock?
Rite Aid (RAD) Plans 400 Job Cuts, Stock Up on Restructuring
by Zacks Equity Research
Rite Aid (RAD) announces leadership transition and organizational revamping in a bid to better align its operations and minimize costs.
Stock Market News For Mar 8, 2019
by Zacks Equity Research
Benchmarks closed in the red for the fourth straight session after ECB reduced its growth forecast for the eurozone economy.
Stock Market News For Mar 7, 2019
by Zacks Equity Research
Benchmarks ended in the red on Wednesday after a slew of weak economic reports weighed on the markets.
Stock Market News For Mar 6, 2019
by Zacks Equity Research
Markets closed in the red on Tuesday as investors refrained from betting big due to lack of any additional factors which would boost stocks.
Walgreens Boots Rides on Retail Pharmacy USA, Strategic Deals
by Zacks Equity Research
Walgreens Boots' (WBA) Retail Pharmacy USA division benefits from comparable prescription growth and a strong retail prescription market.
The Zacks Analyst Blog Highlights: NextEra Energy, Walgreens Boots, Southern Company, Ameriprise Financial and Macy's
by Zacks Equity Research
The Zacks Analyst Blog Highlights: NextEra Energy, Walgreens Boots, Southern Company, Ameriprise Financial and Macy's
Wall Street Takes Notice of These 4 Stocks - Should You?
by Tirthankar Chakraborty
With the market in a volatile state, Wall Street's top investors are sorting the most valuable stocks - should you follow?
Top Research Reports for NextEra Energy, Walgreens Boots & Southern Company
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including NextEra Energy (NEE), Walgreens Boots (WBA) and Southern Company (SO).
Stock Market News For Feb 22, 2019
by Zacks Equity Research
Wall Street closed sharply lower on Thursday as several economic reports from the United States, Eurozone and Japan raised investors' concerns about an impending global economic slowdown.
Dow 30 Stock Roundup: WMT Earnings Beat, MRK's Keytruda sBLA Gets Priority Review
by Swarup Gupta
The index endured a holiday-shortened but volatile week.
CVS Health Stock Pops Before Q4 Earnings: What to Expect
by Benjamin Rains
Let's see what to expect from CVS' fourth-quarter financial results that are due out before the opening bell Wednesday.
Walgreens Boots Alliance (WBA) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Walgreens Boots Alliance (WBA) closed at $72.11, marking a -0.44% move from the previous day.